Loading clinical trials...
Loading clinical trials...
Newborn screening and early treatment prevent the most severe manifestations of phenylketonuria (PKU). However, executive functioning deficits, attention deficit disorder, slow processing speed, and v...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Boston Children's Hospital
Collaborators
NCT06628128 · Phenylketonuria (PKU)
NCT06971731 · Phenylketonuria
NCT05813678 · Phenylketonuria (PKU)
NCT05579548 · Phenylketonuria, Maternal
NCT04404530 · Phenylketonurias
Boston Children's Hospital
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions